COMPARISON OF NONSTEROIDAL ANTI-INFLAMMATORY OF COX-1 AND COX-2 REGARDING SIDE EFFECTS IN THE ASTROINTESTINAL TRACT

Viola Cala, Floreta Kurti, Elizana Petrela, Elona Mollsi

Abstract


Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to treat symptoms caused by rheumatoid arthritis due to their ability to inhibit prostaglandin synthesis by inhibiting cyclooxygenase (COX). The side effects of NSAIDs are also associated with inhibiting prostaglandin production. Consequently, their application is problematic. NSAID selective COX-2 inhibitors give minor gastrointestinal complications. Our study aims to compare nonsteroidal anti-inflammatory inhibitors of COX-1 and COX-2 regarding side effects in the gastrointestinal tract of patients with rheumatoid arthritis.

Keywords:  Nonsteroidal anti-infammatory drugs, rheumatoid arthtritis, COX-2, gastrointestinal tract, PPIs.


Full Text:

PDF

References


Nonsteroidal anti-inflammatory drugs and pain in cancer patients: a systematic review and reappraisal of the evidence. D.J. Magee, S. Jhanji, G. Poulogiannis, P. Farquhar-Smith, M.R.D. BrownBr J Anaesth. 2019 Aug; 123(2): e412–e423.

Marsico, Fabio; Paolillo, Stefania; Filardi, Pasquale P. NSAIDs and cardiovascular risk, Journal of Cardiovascular Medicine: January 2017 - Volume 18-Issue-p e40-e43 doi: 10.2459/JCM.0000000000000443.

Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23; 231(25):232-5.

Adelizzi RA. COX-1 and COX-2 in health and disease. J Am Osteopath Assoc. 1999 Nov; 99(11 Suppl):S7-12.

Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, Lipsky PE. Cyclooxygenase in biology and disease. FASEB J. 1998 Sep; 12(12):1063-73.

Sparks JA. Rheumatoid Arthritis. Ann Intern Med. 2019 Jan 1; 170(1): ITC1-ITC16. Doi: 10.7326/AITC201901010. PMID: 30596879.

Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Rev Dis Primers. 2018 Feb;4:18001.

Ong CK, Lirk P, Tan CH, Seymour RA. An evidence-based update on nonsteroidal anti-inflammatory drugs. Clin Med Res. 2007 Mar; 5((1)):19–34.

Fidahic M, JelicicKadic A, Radic M, Puljak L. Celecoxib for rheumatoid arthritis. Cochrane Database Syst Rev. 2017 Jun 9;6(6):CD012095. doi: 10.1002/14651858.CD012095.pub2. PMID: 28597983; PMCID: PMC6481589.

Cooper C, Chapurlat R, Al-Daghri N, et al. Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?. Drugs Aging. 2019;36(Suppl 1):15-24. doi:10.1007/s40266-019-00660-1.

Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med. 2000; 343:1520–8.

Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature. 1971;231:232-5.

Whittle BJ. Arachidonic acid metabolites and the gastro-intestinal toxicity of anti-inflammatory agents. Prostaglandins. 1981;21 Suppl:113-8.

Vane JR. Towards a better aspirin. Nature. 1994;367:215-6.

Whittle BJR. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and gastrointestinal damage induced by indomethacin in the rat. Gastroenterology. 1981;80:94-8.

Peskar BM. On the synthesis of prostaglandins by human gastric mucosa and its modification by drugs.BiochemBiophysacta. 1977;487:307-14.

Strub KM, Muller RK. Relation between ulcerogenic activity of various NSAID and their potency as inhibitors of prostaglandin synthesis in vivo.Agents Actions. 1979;4 Supplement:245-54.

Bardhan KD, Bjarnason I, Scott DL, et al. The prevention and healing of acute NSAID-associated gastroduodenal mucosal damage by misoprostol.Br J Rheumatol. 1993;32:990-5.

Rostom A, Muir K, Dubé C J, et al. Ga-strointestinal safety of cyclooxygenase-2 inhibitors: a Cochrane Collaboration systematic review. ClinGastroenterolHepatol. 2007;5:818-28.

Whittle BJR. Protective mechanisms of the gastric mucosa. In Gustsavsson S, Kumar D, Graham DY, (eds.) The Stomach. Churchill Livingstone, Edinburgh. 1992:81-101

Brun J, Jones R. Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem. Am J Med. 2001; 110(1A):12S–3S. Epub 2001/02/13.

Cooper C, Chapurlat R, Al-Daghri N, et al. Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?. Drugs Aging. 2019; 36(Suppl 1):15-24. doi:10.1007/s40266-019-00660-1.

Bullock J, Rizvi SAA, Saleh AM, et al. Rheumatoid Arthritis: A Brief Overview of the Treatment. Med PrincPract. 2018;27(6):501-507. doi:10.1159/000493390




DOI (PDF): http://dx.doi.org/10.0001/ijllis.v10i5.2203.g2603

Copyright © 2012-2021 ANGLISTICUM. Journal of the Association-Institute for English Language and American Studies,Tetovo, Republic of North Macedonia.

All Rights Reserved.

The publication is licensed under a Creative Commons License (CC BY) https://creativecommons.org/licenses/by/4.0/  View Legal Code                                                                                                                 

ISSN (print): 1857-8179. ISSN (online): 1857-8187.

Disclaimer: Articles on Anglisticum have been reviewed and authenticated by the Authors before sending for the publication.

The Journal, Editors and the editorial board are not entitled or liable to either justify or responsible for inaccurate and misleading data if any. It is the sole responsibility of the Author concerned.